{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:12:36Z","timestamp":1757452356802,"version":"3.41.0"},"reference-count":53,"publisher":"WHO Press","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. World Health Organ."],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.2471\/blt.16.169524","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T10:48:40Z","timestamp":1477910920000},"page":"826-834A","source":"Crossref","is-referenced-by-count":6,"title":["Hepatitis B immunization for indigenous adults, Australia"],"prefix":"10.2471","volume":"94","author":[{"given":"Andre Louis","family":"Wattiaux","sequence":"first","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Kerry Packer Building, Children\u2019s Hospital at Westmead, corner Hawkesbury Rd and Hainsworth St, Westmead NSW 2145, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Kevin","family":"Yin","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Kerry Packer Building, Children\u2019s Hospital at Westmead, corner Hawkesbury Rd and Hainsworth St, Westmead NSW 2145, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Beard","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Kerry Packer Building, Children\u2019s Hospital at Westmead, corner Hawkesbury Rd and Hainsworth St, Westmead NSW 2145, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Wesselingh","sequence":"additional","affiliation":[{"name":"South Australian Health and Medical Research Institute, Adelaide, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Cowie","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Melbourne, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ward","sequence":"additional","affiliation":[{"name":"South Australian Health and Medical Research Institute, Adelaide, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Kerry Packer Building, Children\u2019s Hospital at Westmead, corner Hawkesbury Rd and Hainsworth St, Westmead NSW 2145, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1305","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"key-10.2471\/BLT.16.169524-201610311148-R1","unstructured":"Estimates of Aboriginal and Torres Strait Islander Australians [3238.0.55.001]. Canberra: Australian Bureau of Statistics; 2013. Available from: http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/3238.0.55.001Main+Features1June%202011?OpenDocument[cited 2013 Nov 5]."},{"article-title":"The burden of disease and injury in Aboriginal and Torres Strait Islander peoples 2003","year":"2007","author":"Vos","key":"key-10.2471\/BLT.16.169524-201610311148-R2"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R3","unstructured":"Life expectancy of Aboriginal and Torres Strait Islander people. Canberra: Australian Institute of Health and Welfare; 2011. Available from: http:\/\/www.aihw.gov.au\/deaths\/life-expectancy\/#indigenous[cited 2016 June 27]."},{"key":"key-10.2471\/BLT.16.169524-201610311148-R4","unstructured":"Closing the gap in indigenous disadvantage [Internet]. Canberra: Council of Australian Governments; 2008. Available from: https:\/\/www.coag.gov.au\/closing_the_gap_in_indigenous_disadvantage[cited 2014 Sept 10]."},{"issue":"9963","key":"key-10.2471\/BLT.16.169524-201610311148-R5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","journal-title":"Lancet"},{"journal-title":"Regional action plan for viral hepatitis in the Western Pacific 2016\u20132020.","year":"2015","key":"key-10.2471\/BLT.16.169524-201610311148-R6"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R7","unstructured":"Significant events in hepatitis B vaccination practice in Australia. Sydney: National Centre for Immunisation Research and Surveillance; 2015. Available from: http:\/\/www.ncirs.edu.au\/assets\/provider_resources\/history\/Hepatitis-B-history-July-2015.pdf[cited 2015 Nov 24]."},{"issue":"1","key":"key-10.2471\/BLT.16.169524-201610311148-R8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/1471-2334-13-403","article-title":"Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis.","volume":"13","author":"Graham","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"5","key":"key-10.2471\/BLT.16.169524-201610311148-R9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1753-6405.12049","article-title":"The burden of chronic hepatitis B virus infection in Australia, 2011.","volume":"37","author":"MacLachlan","year":"2013","journal-title":"Aust N Z J Public Health"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R10","unstructured":"Contribution of chronic disease to the gap in mortality between Aboriginal and Torres Strait Islander people and other Australians [IHW cat. no. 48]. Canberra: Australian Institute of Health and Welfare; 2010."},{"issue":"2","key":"key-10.2471\/BLT.16.169524-201610311148-R11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1023064400004","article-title":"Cancer in Indigenous Australians: a review.","volume":"14","author":"Condon","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"10","key":"key-10.2471\/BLT.16.169524-201610311148-R12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5694\/j.1326-5377.2004.tb06052.x","article-title":"Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory.","volume":"180","author":"Condon","year":"2004","journal-title":"Med J Aust"},{"journal-title":"National hepatitis B strategy 2010\u20132013.","year":"2010","key":"key-10.2471\/BLT.16.169524-201610311148-R13"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R14","unstructured":"National hepatitis B testing policy. Melbourne: National Hepatitis B Virus (HBV) Testing Policy Expert Reference Committee; 2012. Available from: http:\/\/www.nrl.gov.au\/CA25782200833499\/Lookup\/Resources%20%26%20Guidelines\/$file\/HBV_TESTING_POLICY_FORMATTED_V1.1_PRINT.pdf [cited 2016 Aug 16]."},{"journal-title":"The Australian immunisation handbook.","edition":"10th ed.","year":"2013","key":"key-10.2471\/BLT.16.169524-201610311148-R15"},{"issue":"2","key":"key-10.2471\/BLT.16.169524-201610311148-R16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/1753-6405.12316","article-title":"Disparities in hepatitis B vaccine funding in Australian jurisdictions: limiting access for priority populations.","volume":"39","author":"MacLachlan","year":"2015","journal-title":"Aust N Z J Public Health"},{"issue":"6","key":"key-10.2471\/BLT.16.169524-201610311148-R17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5694\/mja14.00121","article-title":"Markers of hepatitis B infection and immunity in patients attending Aboriginal community controlled health services.","volume":"201","author":"Harrod","year":"2014","journal-title":"Med J Aust"},{"journal-title":"National Aboriginal and Torres Strait Islander health survey 2004\u201305.","year":"2006","key":"key-10.2471\/BLT.16.169524-201610311148-R18"},{"journal-title":"Aboriginal surveillance report of HIV, viral hepatitis, STIs.","year":"2015","key":"key-10.2471\/BLT.16.169524-201610311148-R19"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R20","unstructured":"Introduction to the national notifiable diseases surveillance system [Internet]. Canberra: Australian Government Department of Health; 2016. Available from http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-nndssintro.htm [cited 2016 Aug 12]."},{"key":"key-10.2471\/BLT.16.169524-201610311148-R21","unstructured":"Hepatitis B (newly acquired) case definition. Canberra: Communicable Diseases Network Australia; 2004. Available from: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_hepbnew.htm [cited 2016 Aug 12]."},{"key":"key-10.2471\/BLT.16.169524-201610311148-R22","unstructured":"Hepatitis B (unspecified) case definition. Canberra: Communicable Diseases Network Australia; 2004. Available from: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_hepbun.htm[cited 2016 Aug 12]."},{"key":"key-10.2471\/BLT.16.169524-201610311148-R23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.33321\/cdi.2013.37.64","article-title":"Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006\u20132010.","volume":"37","author":"Naidu","year":"2013","journal-title":"Commun Dis Intell Q Rep"},{"issue":"9","key":"key-10.2471\/BLT.16.169524-201610311148-R24","doi-asserted-by":"crossref","first-page":"638","DOI":"10.5694\/j.1326-5377.1992.tb121461.x","article-title":"Hepatitis B virus markers in children and staff in Northern Territory schools.","volume":"156","author":"Gardner","year":"1992","journal-title":"Med J Aust"},{"issue":"3","key":"key-10.2471\/BLT.16.169524-201610311148-R25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1467-842X.2004.tb00697.x","article-title":"Estimates of chronic hepatitis B virus infection in Australia, 2000.","volume":"28","author":"O\u2019Sullivan","year":"2004","journal-title":"Aust N Z J Public Health"},{"issue":"10","key":"key-10.2471\/BLT.16.169524-201610311148-R26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.1983.tb122616.x","article-title":"Hepatitis B reservoirs and attack rates in an Australian community. A basis for vaccination and crossinfection policies.","volume":"2","author":"Burrell","year":"1983","journal-title":"Med J Aust"},{"issue":"5","key":"key-10.2471\/BLT.16.169524-201610311148-R27","first-page":"641","article-title":"Risk factors associated with hepatitis B infection in antenatal patients.","volume":"15","author":"Britton","year":"1985","journal-title":"Aust N Z J Med"},{"issue":"1","key":"key-10.2471\/BLT.16.169524-201610311148-R28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5694\/j.1326-5377.1990.tb125461.x","article-title":"Markers of hepatitis B virus infection in schoolchildren in the Kimberley, Western Australia.","volume":"153","author":"Gill","year":"1990","journal-title":"Med J Aust"},{"issue":"2","key":"key-10.2471\/BLT.16.169524-201610311148-R29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.33321\/cdi.2004.28.11","article-title":"Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.","volume":"28","author":"Menzies","year":"2004","journal-title":"Commun Dis Intell Q Rep"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R30","first-page":"S2","article-title":"Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.","volume":"32","author":"Menzies","year":"2008","journal-title":"Commun Dis Intell Q Rep"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R31","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R32","first-page":"205","author":"Van Damme","year":"2012","edition":"6th ed.","journal-title":"Vaccines."},{"issue":"6 Pt 1","key":"key-10.2471\/BLT.16.169524-201610311148-R33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1542\/peds.103.6.1243","article-title":"Hepatitis B vaccine administered to children and adolescents at yearly intervals.","volume":"103","author":"Halsey","year":"1999","journal-title":"Pediatrics"},{"issue":"5","key":"key-10.2471\/BLT.16.169524-201610311148-R34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/infdis\/160.5.766","article-title":"Vaccination against hepatitis B: comparison of three different vaccination schedules.","volume":"160","author":"Jilg","year":"1989","journal-title":"J Infect Dis"},{"issue":"4","key":"key-10.2471\/BLT.16.169524-201610311148-R35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1542\/peds.107.4.626","article-title":"A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.","volume":"107","author":"Cassidy","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"key-10.2471\/BLT.16.169524-201610311148-R36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/1054-139X(94)00105-N","article-title":"Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.","volume":"16","author":"Schiff","year":"1995","journal-title":"J Adolesc Health"},{"issue":"840","key":"key-10.2471\/BLT.16.169524-201610311148-R37","first-page":"67","article-title":"Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.","volume":"101","author":"Milne","year":"1988","journal-title":"N Z Med J"},{"issue":"3","key":"key-10.2471\/BLT.16.169524-201610311148-R38","doi-asserted-by":"publisher","first-page":"14S","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.","volume":"87","author":"Andr\u00e9","year":"1989","journal-title":"Am J Med"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0163-4453(86)92668-X","article-title":"Overview of clinical studies with hepatitis B vaccine made by recombinant DNA.","volume":"13","author":"Zajac","year":"1986","journal-title":"J Infect"},{"issue":"6","key":"key-10.2471\/BLT.16.169524-201610311148-R40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0025-7125(16)30493-X","article-title":"The emergence of hepatitis B as a sexually transmitted disease.","volume":"74","author":"Alter","year":"1990","journal-title":"Med Clin North Am"},{"issue":"1","key":"key-10.2471\/BLT.16.169524-201610311148-R41","first-page":"36","article-title":"Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation.","volume":"88","author":"Aspinall","year":"1998","journal-title":"S Afr Med J"},{"issue":"2","key":"key-10.2471\/BLT.16.169524-201610311148-R42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0923-2516(97)89893-7","article-title":"Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.","volume":"148","author":"Da Villa","year":"1997","journal-title":"Res Virol"},{"issue":"7","key":"key-10.2471\/BLT.16.169524-201610311148-R43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/00006454-199607000-00006","article-title":"Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.","volume":"15","author":"Greenberg","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R44","first-page":"282","article-title":"Hepatitis B immunization: vaccine types, efficacy, and indications for immunization.","volume":"12","author":"Hadler","year":"1992","journal-title":"Curr Clin Top Infect Dis"},{"issue":"1337","key":"key-10.2471\/BLT.16.169524-201610311148-R45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state.","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci"},{"journal-title":"National blood-borne virus and sexually transmissible infections surveillance and monitoring report.","year":"2013","key":"key-10.2471\/BLT.16.169524-201610311148-R46"},{"issue":"40","key":"key-10.2471\/BLT.16.169524-201610311148-R47","first-page":"405","article-title":"Hepatitis B vaccines.","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"key-10.2471\/BLT.16.169524-201610311148-R48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact.","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"key-10.2471\/BLT.16.169524-201610311148-R49","unstructured":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015. Available from: http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-b-guidelines\/en\/[cited 2016 Aug 12]."},{"issue":"2","key":"key-10.2471\/BLT.16.169524-201610311148-R50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/hep.23310","article-title":"Cost\u2013effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.","volume":"51","author":"Hutton","year":"2010","journal-title":"Hepatology"},{"issue":"48","key":"key-10.2471\/BLT.16.169524-201610311148-R51","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1016\/j.vaccine.2015.09.011","article-title":"An economic analysis of adult hepatitis B vaccination in China.","volume":"33","author":"Zheng","year":"2015","journal-title":"Vaccine"},{"journal-title":"Housing circumstances of indigenous households: tenure and overcrowding.","year":"2014","key":"key-10.2471\/BLT.16.169524-201610311148-R52"},{"issue":"2","key":"key-10.2471\/BLT.16.169524-201610311148-R53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/1753-6405.12434","article-title":"Using data linkage to improve the completeness of Aboriginal and Torres Strait Islander status in communicable disease notifications in Victoria.","volume":"40","author":"Rowe","year":"2016","journal-title":"Aust N Z J Public Health"}],"container-title":["Bulletin of the World Health Organization"],"original-title":[],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:40:56Z","timestamp":1749681656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5096351\/pdf\/BLT.16.169524.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,9,16]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.2471\/blt.16.169524","relation":{},"ISSN":["0042-9686"],"issn-type":[{"type":"print","value":"0042-9686"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}